We are live on ! Find out more
CALA

Calithera Biosciences

Delisted

CALA was delisted on the 1st of February, 2023.

49 hedge funds and large institutions have $49.4M invested in Calithera Biosciences in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

145% more capital inflows, than outflows

Capital inflows: $10.2M | Capital outflows: $4.14M

78% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 9

5.42% more ownership

Funds ownership: 44.84% → 50.26% (+5.4%)

6% less funds holding

Funds holding: 52 → 49 (-3)

25% less call options, than puts

Call options by funds: $216K | Put options by funds: $287K

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

Holders
49
Holders Change
-3
Holders Change %
-5.77%
% of All Funds
1.36%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
9
Increased
16
Reduced
9
Closed
12
Calls
$216K
Puts
$287K
Net Calls
-$71K
Net Calls Change
+$134K

CALA Hedge Fund Activity: Q3 2015 in Review

49 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences (CALA) for Q3 2015, worth a combined $49.4M — down 15% from $58M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of CALA and 9 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 16 added.

The largest buyer was BVF Inc, opening a new position worth an estimated $2.96M. The largest seller was Numeric Investors, exiting entirely with an estimated $2.39M sold.

  • 49 institutional investors held Calithera Biosciences (CALA) as of Q3 2015, down from 52 in Q2 2015.
  • Funds reported $49.4M of Calithera Biosciences stock for Q3 2015, down 15% quarter-over-quarter.
  • 9 funds opened new Calithera Biosciences positions in Q3 2015 and 12 closed out, a net change of -3 holders.
  • The largest Calithera Biosciences buyer in Q3 2015 was BVF Inc, an estimated $2.96M added.
  • The largest Calithera Biosciences seller in Q3 2015 was Numeric Investors, an estimated $2.39M sold.

Based on aggregated 13F filings for Q3 2015.